Literature DB >> 1912778

Prevalence of multiple sclerosis in five rural Suffolk practices.

M J Lockyer.   

Abstract

OBJECTIVE: To determine a point prevalence of multiple sclerosis in part of Suffolk.
DESIGN: Multiple source search for patients with multiple sclerosis in five general practices. Patients were reviewed and categorised by using general practice notes.
SETTING: Five rural general practices in Suffolk, 12 May 1988.
SUBJECTS: 31,379 patients registered with five practices. MAIN OUTCOME MEASURES: Multiple sclerosis diagnosed by a specialist.
RESULTS: The search produced a provisional list of 62 eligible patients with multiple sclerosis. Review of case notes showed that 48 had probable disease, 10 early disease, and four possible disease. The probable cases gave a crude prevalence of 153/100,000 population (95% confidence interval 109/100,000 to 196/100,000).
CONCLUSIONS: Although the results should be interpreted cautiously because of the small sample size, they suggest that the prevalence of multiple sclerosis in Suffolk is higher than has been estimated from hospital data.

Entities:  

Mesh:

Year:  1991        PMID: 1912778      PMCID: PMC1670776          DOI: 10.1136/bmj.303.6798.347

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  4 in total

1.  EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THE COUNTIES OF NORTHUMBERLAND AND DURHAM.

Authors:  D C POSKANZER; K SCHAPIRA; H MILLER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-08       Impact factor: 10.154

2.  A further prevalence study of multiple sclerosis in north-east Scotland.

Authors:  D I Shepherd; A W Downie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

3.  Prevalence of disseminated sclerosis in the Faroes, the Orkneys and Shetland.

Authors:  M Fog; K Hyllested
Journal:  Acta Neurol Scand       Date:  1966       Impact factor: 3.209

4.  Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.

Authors:  D C Poskanzer; L B Prenney; J L Sheridan; J Y Kondy
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

  4 in total
  9 in total

Review 1.  Multiple sclerosis: it epidemiological, genetic, and health care impact.

Authors:  R Williams; A S Rigby; M Airey; M Robinson; H Ford
Journal:  J Epidemiol Community Health       Date:  1995-12       Impact factor: 3.710

2.  Surveying multiple sclerosis in the United Kingdom.

Authors:  N Robertson; A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

3.  Multiple sclerosis in the Cambridge health district of east Anglia.

Authors:  C J Mumford; M B Fraser; N W Wood; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

4.  Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.

Authors:  G Sharpe; S E Price; A Last; R J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

5.  Multiple sclerosis in the north Cambridgeshire districts of East Anglia.

Authors:  N Robertson; J Deans; M Fraser; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

6.  Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.

Authors:  C McGuigan; A McCarthy; C Quigley; L Bannan; S A Hawkins; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

7.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

8.  Multiple sclerosis in Northern Ireland: a historical and global perspective.

Authors:  G V McDonnell; S A Hawkins
Journal:  Ulster Med J       Date:  2000-11

Review 9.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.